Abstract
Various retinal conditions can mimic inherited retinal diseases, especially retinitis pigmentosa (RP). Some are phenocopies of RP, and they can be differentiated from RP based on careful fundus examination and thorough systemic review. Meanwhile, others are pseudo-RP diseases, which are not true genetic diseases but are pan-retinal damage caused by conditions other than heredity. A number of acquired conditions can present with diffuse chorioretinal atrophy which is very difficult to distinguish from advanced RP. Specific medical history and asymmetry of retinal degenerative change are important clues for differential diagnosis, which is critical because it can prevent the burden of genetic and prognostic counseling and some conditions may be treatable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brown TH. Retino-choroiditis radiata. Br J Ophthalmol. 1937;21(12):645–8. https://doi.org/10.1136/BJO.21.12.645.
Limaye SR, Mahmood MA. Retinal microangiopathy in pigmented paravenous chorioretinal atrophy. Br J Ophthalmol. 1987;71(10):757–61. https://doi.org/10.1136/BJO.71.10.757.
Lee EK, Lee SY, Oh BL, Yoon CK, Park UC, Yu HG. Pigmented paravenous chorioretinal atrophy: clinical spectrum and multimodal imaging characteristics. Am J Ophthalmol. 2021;224:120–32. https://doi.org/10.1016/J.AJO.2020.12.010.
McKay GJ, Clarke S, Davis JA, Simpson DAC, Silvestri G. Pigmented paravenous chorioretinal atrophy is associated with a mutation within the crumbs homolog 1 (CRB1) gene. Invest Ophthalmol Vis Sci. 2005;46(1):322–8. https://doi.org/10.1167/IOVS.04-0734.
Kellner U, Helbig H, Foerster MH. [Phenocopies of hereditary retinal degenerations]. Ophthalmologe. 1996;93(6):680–7. https://doi.org/10.1007/S003470050058
Peduzzi M, Guerrieri F, Torlai F, Prampolini ML. Bilateral pigmented paravenous retino-choroidal degeneration following measles. Int Ophthalmol. 1984;7(1):11–4. https://doi.org/10.1007/BF00138263.
Yamaguchi K, Hara S, Tanifuji Y, Tamai M. Inflammatory pigmented paravenous retinochoroidal atrophy. Br J Ophthalmol. 1989;73(6):463–7. https://doi.org/10.1136/BJO.73.6.463.
Cicinelli MV, Giuffrè C, Rabiolo A, Parodi MB, Bandello F. Optical coherence tomography angiography of pigmented paravenous retinochoroidal atrophy. Ophthalmic Surg Lasers Imaging Retina. 2018;49(5):381–3. https://doi.org/10.3928/23258160-20180501-14.
Kalatzis V, Hamel CP, Macdonald IM. Choroideremia: towards a therapy. Am J Ophthalmol. 2013;156(3):433–7.e3. https://doi.org/10.1016/J.AJO.2013.05.009
Preising M, Ayuso C. Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview. Ophthalmic Genet. 2004;25(2):101–10. https://doi.org/10.1080/13816810490514333.
Sanchez-Alcudia R, Garcia-Hoyos M, Lopez-Martinez MA, et al. A comprehensive analysis of choroideremia: from genetic characterization to clinical practice. PLoS One. 2016;11(4):e0151943. https://doi.org/10.1371/JOURNAL.PONE.0151943.
Friberg TR. Traumatic retinal pigment epithelial edema. Am J Ophthalmol. 1979;88(1):18–21. https://doi.org/10.1016/0002-9394(79)90745-1.
Ahn SJ, Woo SJ, Park KH, Lee BR. Retinal pigment epithelium sequelae caused by blunt ocular trauma: incidence, visual outcome, and associated factors. Sci Rep. 2017;7(1):1–8. https://doi.org/10.1038/s41598-017-14659-4
Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004;4:1–9. https://doi.org/10.1186/1471-2415-4-5.
Mantel I, Ramchand KV, Holder GE, et al. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology. Exp Mol Pathol. 2008;84(2):90–101. https://doi.org/10.1016/J.YEXMP.2007.10.006.
Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol. 2005;139(5):780–94. https://doi.org/10.1016/J.AJO.2004.12.104.
Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48(1):12–38. https://doi.org/10.1016/S0039-6257(02)00416-2.
Cooper LZ, Krugman S. Clinical manifestations of postnatal and congenital rubella. Arch Ophthalmol. 1967;77(4):434–9. https://doi.org/10.1001/ARCHOPHT.1967.00980020436004.
Menne K. Kongenitale Rötelnretinopathie—eine progressive Erkrankung. Klin Monbl Augenheilkd. 2008;189(10):326–9. https://doi.org/10.1055/S-2008-1050812.
Cristiani R. [Sectorial pigmented retinopathy secondary to acquired syphilis]. Ann Ottalmol Clin Ocul. 1967;93(10):1099–108. https://pubmed.ncbi.nlm.nih.gov/5605815/. Accessed July 12, 2021.
Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1(1):1–12. https://doi.org/10.1186/1750-1172-1-40
Sevgi DD, Davoudi S, Comander J, Sobrin L. Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1801–10. https://doi.org/10.1007/S00417-017-3689-7.
Newsome DA. Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol. 1986;101(3):354–60. https://doi.org/10.1016/0002-9394(86)90831-7.
Consugar MB, Navarro-Gomez D, Place EM, et al. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med. 2014;17(4):253–61. https://doi.org/10.1038/gim.2014.172.
Tobin DR, Krohel GB, Rynes RI. Hydroxychloroquine: seven-year experience. Arch Ophthalmol. 1982;100(1):81–3. https://doi.org/10.1001/ARCHOPHT.1982.01030030083006.
Kellner U, Kellner S, Weinitz S. Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol. 2007;116(2):119–27. https://doi.org/10.1007/S10633-007-9105-6.
Farag TI, Teebi AS. Bardet-Biedl and Laurence-Moon syndromes in a mixed Arab population. Clin Genet. 1988;33(2):78–82. https://doi.org/10.1111/J.1399-0004.1988.TB03414.X.
Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum. 1997;40(8):1482–6. https://doi.org/10.1002/ART.1780400817.
Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110(7):1321–6. https://doi.org/10.1016/S0161-6420(03)00409-3.
Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology. 2002;109(7):1377–82. https://doi.org/10.1016/S0161-6420(02)01168-5.
Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF, Lum F. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–94. https://doi.org/10.1016/J.OPHTHA.2016.01.058.
Hagopian V, Stratton DB, Busiek RD. Five cases of pigmentary retinopathy associated with thioridazine administration. Am J Psychiatry. 1996;123(1):97–100. https://doi.org/10.1176/AJP.123.1.97.
Meredith TA, Aaberg TM, Willerson WD. Progressive chorioretinopathy after receiving thioridazine. Arch Ophthalmol. 1978;96(7):1172–6. https://doi.org/10.1001/ARCHOPHT.1978.03910060006002.
Miller FS, Bunt-Milam AH, Kalina RE. Clinical-ultrastructural study of thioridazine retinopathy. Ophthalmology. 1982;89(12):1478–88. https://doi.org/10.1016/S0161-6420(82)34613-8.
Farrell DF. Unilateral retinitis pigmentosa and cone-rod dystrophy. Clin Ophthalmol. 2009;3(1):263–70. https://doi.org/10.2147/OPTH.S5130.
Lommatzsch PK, Jensen OA, Prause JU, Bauke G. [Pseudoneuritis pigmentosa in malignant melanoma of the choroid]. Klin Monbl Augenheilkd. 1988;193(1):69–74. https://doi.org/10.1055/S-2008-1050226
Silveira C, Belfort R Jr, Nussenblatt R, et al. Unilateral pigmentary retinopathy associated with ocular toxoplasmosis. Am J Ophthalmol. 1989;107(6):682–4. https://doi.org/10.1016/0002-9394(89)90274-2.
Jaissle GB, May CA, van de Pavert SA, et al. Bone spicule pigment formation in retinitis pigmentosa: insights from a mouse model. Graefes Arch Clin Exp Ophthalmol. 2010;248(8):1063–70. https://doi.org/10.1007/S00417-009-1253-9.
Errera M-H, Robson AG, Wong T, et al. Unilateral pigmentary retinopathy: a retrospective case series. Acta Ophthalmol. 2019;97(4):e601–17. https://doi.org/10.1111/AOS.13981.
Poduri A, Evrony GD, Cai X, Walsh CA. Somatic mutation, genomic variation, and neurological disease. Science. 2013;341(6141). https://doi.org/10.1126/SCIENCE.1237758
Gass JDM, Gilbert WR, Guerry RK, Scelfo R. Diffuse unilateral subacute neuroretinitis. Ophthalmology. 1978;85(5):521–45. https://doi.org/10.1016/S0161-6420(78)35645-1.
Gass JDM, Braunstein RA. Further observations concerning the diffuse unilateral subacute neuroretinitis syndrome. Arch Ophthalmol. 1983;101(11):1689–97. https://doi.org/10.1001/ARCHOPHT.1983.01040020691004.
Gass JDM, Callanan DG, Bowman CB. Oral therapy in diffuse unilateral subacute neuroretinitis. Arch Ophthalmol. 1992;110(5):675–80. https://doi.org/10.1001/ARCHOPHT.1992.01080170097031.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Park, U.C. (2022). Retinal Disorders Mimicking Inherited Retinal Diseases. In: Yu, HG. (eds) Inherited Retinal Disease. Springer, Singapore. https://doi.org/10.1007/978-981-16-7337-5_17
Download citation
DOI: https://doi.org/10.1007/978-981-16-7337-5_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-7336-8
Online ISBN: 978-981-16-7337-5
eBook Packages: MedicineMedicine (R0)